Connect with us

Uncategorized

Juganu begins selling its tunable lighting system for pathogen disinfection and deactivation in the US

Published

on

Juganu, the venture-backed Israeli company that makes lighting systems capable of emitting light at specified wavelengths, is now selling a product that it claims can disinfect surfaces and deactivate pathogens in an attempt to provide buildings with new safety technologies that can prevent the spread of the coronavirus that causes COVID-19.

The company claims that its J.Protect product was clinically validated through a study conducted by Dr. Meital Gal-Tanamy at the Bar-Ilan University Faculty of Medicine (although Dr. Gal-Tanamy’s research typically focuses on the Hepatitis C virus, which has a different transmission vector than airborne viruses like Sars-Cov-2, the coronavirus that causes COVID-19).

Juganu said that the new product has been registered with the US Environmental Protection Agency in 46 states and is currently working with Comcast, Qualcomm, and NCR Corp. to bring its lighting disinfectant and deactivation technology to markets around the country.

The lighting technology uses two kinds of ultraviolet light — A and C — to render viruses inert and kill bacteria on surfaces, according to the company’s claims.

When people are present in a room, the company’s system uses UVA light which can render viruses inert after eight hours of exposure. If the room is empty, the lighting system will use UVC light, which is more potent as disinfectant and more harmful to people, to disinfect a room in under an hour.

The company tested its technology on surfaces, but did not conduct any tests involving their lighting system’s effects on aerosolized viral particles, which have been determined to be the main cause of infections from the novel coronavirus.

“We got an exemption from the FDA and are approved for distribution by the EPA in 48 states,” said Juganu chief executive, Eran Ben-Shmuel in an interview.

The company has already pre-sold the lighting technology in Israel and in India, according to Ben-Shmuel, and is now taking orders for installations in the US.

Juganu, which has raised $53 million to date from investors including Comcast Ventures, Viola Growth, Amdocs, and OurCrowd has offices in Israel, Brazil, Mexico, and the US, has already sold lighting systems to municipalities and businesses around the country.

The new hardware opens up a new line of business in the booming market for technologies targeting the reopening of businesses in the nations that have been hit the hardest by the COVID-19 pandemic.

“Smart lighting will be one of the biggest areas of opportunity for physical spaces. We are evolving from lights simply illuminating spaces to disinfecting and securing them, as well as promoting well-being by recreating natural light shifts based on sunrise and sunset,” said Ben-Shmuel, in a statement. 

 

Continue Reading
Comments

Uncategorized

Teardown of “Dishy McFlatface,” the SpaceX Starlink user terminal

Published

on

The outer part of

Enlarge / Ken Keiter gets ready to tear apart the SpaceX Starlink user terminal, “Dishy McFlatface.” (credit: Ken Keiter)

Engineer Ken Keiter recently came into possession of one SpaceX Starlink user terminal, the satellite dish that SpaceX nicknamed “Dishy McFlatface.” But instead of plugging it in and getting Internet access from SpaceX’s low Earth orbit (LEO) satellites, Keiter decided to take Dishy apart to see what’s inside.

The teardown process destroyed portions of the device. “I would love to actually test out the [Starlink] service and clearly I didn’t get a chance to, as this went a little bit further than I was intending,” Keiter said toward the end of the 55-minute teardown video he posted on YouTube last week.

Keiter, who lives in Portland, Oregon, was impressed by the Starlink team’s work. “It’s rare to see something of this complexity in a consumer product,” he said in reference to the device’s printed circuit board (PCB), which he measured at 19.75″ by 21.5″.

Read 10 remaining paragraphs | Comments

Continue Reading

Uncategorized

Salesforce applies AI to workflow with Einstein Automate

Published

on

While Salesforce made a big splash yesterday with the announcement that it’s buying Slack for $27.7 billion, it’s not the only thing going on for the CRM giant this week. In fact Dreamforce, the company’s customer extravaganza is also on the docket. While it is virtual this year, there are still product announcements aplenty and today the company announced Einstein Automate, a new AI-fueled set of workflow solutions.

Sarah Franklin, EVP & GM of Platform, Trailhead and AppExchange at Salesforce says that she is seeing companies facing a digital imperative to automate processes as things move ever more quickly online, being driven there even faster by the pandemic. “With Einstein Automate, everyone can change the speed of work and be more productive through intelligent workflow automation,” she said in a statement.

Brent Leary, principal analyst at CRM Essentials says that combined these tools are designed to help customers get to work more quickly. “It’s not only about identifying the insight, it’s about making it easier to leverage it at the the right time. And this should make it easier for users to do it without spending more time and effort,” Leary told TechCrunch.

Einstein is the commercial name given to Salesforce’s artificial intelligence platform that touches every aspect of the company’s product line, bringing automation to many tasks and making it easier to find the most valuable information on customers, which is often buried in an avalanche of data.

Einstein Automate encompasses several products designed to improve workflows inside organizations. For starters, the company has created Flow Orchestrator, a tool that uses a low-code, drag and drop approach for building workflows, but it doesn’t stop there. It also relies on AI to provide help suggest logical next steps to speed up workflow creation.

Salesforce is also bringing Mulesoft, the integration company it bought for $6.5 billion in 2018 into the mix. Instead of processes like a mortgage approval workflow, the Mulesoft piece lets IT build complex integrations between applications across the enterprise, and the Salesforce family of products more easily.

To make it easier to build these workflows, Salesforce is announcing the Einstein Automate collection page available in AppExchange, the company’s application marketplace. The collection includes over 700 pre-built connectors so customers can grab and go as they build these workflows, and finally it’s updating the OmniStudio, their platform for generating customer experiences. As Salesforce describes it, “Included in OmniStudio is a suite of resources and no-code tools, including pre-built guided experiences, templates and more, allowing users to deploy digital-first experiences like licensing and permit applications quickly and with ease. ”

Per usual with Salesforce Dreamforce announcements, the Flow Orchestrator being announced today won’t be available in beta until next summer. The Mulesoft component will be available in early 2021, but the OmniStudio updates and the Einstein connections collection are available today.

Continue Reading

Uncategorized

Virta Health’s behavioral diabetes treatment service is now worth over $1 billion

Published

on

A new $65 million investment led by the growth capital and public investment arm of Sequoia Capital will give Virta Health, a developer of a behavioral-focused diabetes treatment, a valuation of over $1 billion.

Virta’s approach, which uses a combination of approaches to change diet and exercise to reverse the presence of type 2 diabetes and other chronic metabolic conditions, has shown clinical success and attracted 100 health care payers to endorse the company’s treatments.

“We partnered with Virta for their ability to deliver unmatched health improvement and cost savings—two clear differentiators from other offerings on the market,” said William Ashmore, CEO of the State Employees’ Insurance Board of Alabama, in a statement. “Especially amid the COVID-19 pandemic, it’s vital that we provide our members the life-changing results Virta is known for delivering, through expert, virtual care delivered right to their home.”

The company said it would use the funding to expand sales and marketing efforts for its services as well as expand its research and development into other non-pharmaceutical therapies for metabolic conditions.

The financing came from Sequoia Capital Global Equities and Caffeinated Capital and brings the company’s total funding to over $230 million and gives it a $1.1 billion valuation, according to a statement.

Alongside Sequoia Capital Global Equities, Caffeinated Capital participated in the round, which brings total funding to more than $230 million and values Virta Health at over $1.1 billion.

Diabetes has long been an attractive condition for startups and has been the first target that companies focused on behavior changes to influence metabolic conditions aim to address. The reason why there are so many diabetes-focused businesses is because of the prevalence of the disease in the U.S. Almost half of adults in the U.S. suffer from obesity, pre-diabetes, or type 2 diabetes and the disease kills thirty people every hour. Diabetes also doubles the risk of death from COVID-19 infections.

Beyond the risks, the costs of treatment are skyrocketing. According to data from the American Diabetes Association released in March 2018, the total costs of treating diagnosed diabetes have risen to $327 billion in 2017 from $245 billion in 2012, when the cost was last examined.

“Given the scope of the metabolic crisis in the U.S. and globally, it cannot be understated how game-changing Virta’s results and care delivery are,” said Patrick Fu, managing partner at Sequoia Capital Global Equities, in a statement. “Virta’s technology-driven, non-pharmaceutical approach has fundamentally changed how diabetes is cared for, and our collective belief in what is possible for population health improvement. This is the future of chronic disease care.”

Continue Reading

Trending